01:46 : Japanese group in £292m deal for ProStrakan -
Japan's Kyowa Hakko Kirin Co has unveiled plans to raise it global profile by agreeing to buy the Scottish pharmaceuticals firm ProStrakan in a £292m deal.
00:33 : London small caps: Prostrakan shares rise on bid agreement -
Analysts say there is a chance of a counter bid from Norgine, which has a 13.5% stake, or from Paladin, which holds an option to buy a 19% holding at 110p per share
11:24 : Scottish biotech star bought by Japanese drugmaker -
ProStrakan is one of Scotland's most promising drugmakers and specialises in pain relief treatments for cancer patientsJapan's Kyowa Hakko Kirin has agreed to buy ProStrakan for £292m, following a tussle between pharmaceutical ...